Evidence Supporting US Food and Drug Administration Drug Safety Communications

被引：3
|
作者：
Ross, Joseph S. [1 ]
机构：
[1] Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, 367 Cedar St,Harkness 4A-405, New Haven, CT 06520 USA
来源：
JAMA INTERNAL MEDICINE | 2019年 / 179卷 / 11期
关键词：
D O I：
10.1001/jamainternmed.2019.3065
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1592 / 1592
页数：1
相关论文
共 50 条
  • [1] Review of Evidence Supporting 2022 US Food and Drug Administration Drug Approvals
    Kaplan, Robert M.
    Koong, Amanda J.
    Irvin, Veronica
    [J]. JAMA NETWORK OPEN, 2023, 6 (08) : e2327650
  • [2] Association Between Data Sources and US Food and Drug Administration Drug Safety Communications
    Tau, Noam
    Shochat, Tzippy
    Gafter-Gvili, Anat
    Tibau, Ariadna
    Amir, Eitan
    Shepshelovich, Daniel
    [J]. JAMA INTERNAL MEDICINE, 2019, 179 (11) : 1590 - 1592
  • [3] Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications
    Desai, Ravi J.
    Good, Meghan M.
    San-Juan-Rodriguez, Alvaro
    Henriksen, Andrew
    Cunningham, Francesca
    Hernandez, Inmaculada
    Good, Chester B.
    [J]. JAMA NETWORK OPEN, 2019, 2 (09)
  • [4] Clinical Evidence Supporting Pharmacogenomic Biomarker Testing Provided in US Food and Drug Administration Drug Labels
    Wang, Bo
    Canestaro, William J.
    Choudhry, Niteesh K.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (12) : 1938 - 1944
  • [5] Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration
    Puthumana, Jeremy
    Egilman, Alexander C.
    Zhang, Audrey D.
    Schwartz, Jason L.
    Ross, Joseph S.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (04) : 559 - 560
  • [6] Cardiovascular Safety Communications After US Food and Drug Administration Approval of Contemporary Cancer Therapies
    Bonsu, Janice M.
    Kola-Kehinde, Onaopepo
    Kim, Lisa
    Ruz, Patrick
    Campbell, Courtney M.
    Brammer, Jonathan E.
    Addison, Daniel
    [J]. JAMA ONCOLOGY, 2021, 7 (11) : 1722 - 1723
  • [7] Assessment of Data Sources That Support US Food and Drug Administration Medical Devices Safety Communications
    Tau, Noam
    Shepshelovich, Daniel
    [J]. JAMA INTERNAL MEDICINE, 2020, 180 (11) : 1420 - 1426
  • [8] Clinical Evidence Supporting US Food and Drug Administration Approval of Otolaryngologic Prescription Drug Indications, 2005-2014
    Rathi, Vinay K.
    Wang, Bo
    Ross, Joseph S.
    Downing, Nicholas S.
    Kesselheim, Aaron S.
    Gray, Stacey T.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 156 (04) : 683 - 692
  • [9] Key Evidence Supporting Prescription Opioids Approved by the US Food and Drug Administration, 1997 to 2018
    Heyward, James
    Moore, Thomas J.
    Chen, Jennifer
    Meek, Kristin
    Lurie, Peter
    Alexander, G. Caleb
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 173 (12) : 956 - +
  • [10] US food and drug administration
    Goodman, Jesse
    [J]. ONCOLOGY-NEW YORK, 2006, 20 (08): : 946 - 946
12345